A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery
Clinical trial NCT04026412 · COMPLETED
Trial details
- NCT number
- NCT04026412
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2024-03-22
- Enrollment
- 925
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.